Molecular Mechanisms of β-Lactam Resistance and Its Contribution to Multidrug Resistance in Helicobacter pylori
The Journal of Infectious Diseases · 13.03.2026 · 233 (Supplement_1) · S10-S20
DOI: 10.1093/infdis/jiaf385 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 10.03.2026. Verfasst von Jun Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu,…. Hauptthemen laut MEDLINE: Helicobacter pylori, Drug Resistance, Multiple, Bacterial, beta-Lactam Resistance, Helicobacter Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 109 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Postdoctoral Science Foundation of China, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
Helicobacter pylori is a significant pathogen associated with a range of diseases, most notably gastritis and gastric cancer, making it a critical target for medical intervention. β-lactam antibiotics, known for their potent bactericidal properties, play a central role in clinical regimens aimed at eradicating H pylori. However, the increasing resistance of H pylori to β-lactams, compounded by the rise of multidrug-resistant strains, presents a major challenge to effective treatment. The molecular mechanisms underlying β-lactam resistance in H pylori are multifactorial, including (1) mutations in penicillin-binding proteins, (2) production of β-lactamases, (3) alterations in outer membrane permeability, and (4) activation of efflux pumps. These mechanisms not only reduce the efficacy of β-lactam antibiotics but also contribute to the emergence of multidrug-resistant H pylori strains. Understanding these molecular pathways is essential for the development of novel therapeutic strategies to overcome resistance and enhance the effectiveness of treatment for H pylori infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Laboratory of Infectious and Liver Diseases, Institution of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
- West China Clinical Medical College of Sichuan University, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Förderung
- National Natural Science Foundation of China
- Postdoctoral Science Foundation of China
- Natural Science Foundation of Sichuan Province
- International Cooperation Excellence Initiative Grant
- West China Hospital
- Sichuan University
Zitieren
APA
Zhou, J., Tang, X., He, L., Zhang, F., Mou, X., Zhao, N., Li, H., & Bao, R. (2026). Molecular Mechanisms of β-Lactam Resistance and Its Contribution to Multidrug Resistance in Helicobacter pylori. The Journal of Infectious Diseases, 233(Supplement_1), S10-S20. https://doi.org/10.1093/infdis/jiaf385
Vancouver
Zhou J, Tang X, He L, Zhang F, Mou X, Zhao N, et al. Molecular Mechanisms of β-Lactam Resistance and Its Contribution to Multidrug Resistance in Helicobacter pylori. The Journal of Infectious Diseases. 2026;233(Supplement_1):S10-S20. doi:10.1093/infdis/jiaf385
BibTeX
@article{Zhou2026,
author = {Zhou, Jun and Tang, Xiaoqiong and He, Liqing and Zhang, Fandi and Mou, Xingyu and Zhao, Ninglin and Li, Hong and Bao, Rui},
title = {Molecular Mechanisms of β-Lactam Resistance and Its Contribution to Multidrug Resistance in Helicobacter pylori},
journal = {The Journal of Infectious Diseases},
year = {2026},
volume = {233},
number = {Supplement_1},
pages = {S10--S20},
doi = {10.1093/infdis/jiaf385}
}
EUVIMED